Inventor · disambiguated record
Christopher P. Price
Also filed as: PRICE CHRISTOPHER · PRICE CHRISTOPHER P · PRICE CHRISTOPHER PHILIP
14 granted patents·11 pending applications·92 citations·filing 1981–2024
91Inventor score
Files withBIOMARIN PHARM INC10OGBURN MICHAEL4HEALTH LAB SERVICE BOARD3PINATA HOLDINGS INC3WENDT DANIEL J2
Top patents by PatentIndex Score
25 records- 0194US8198242B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2010·Granted Jun 12, 2012·46 cites·17 claims
- 0292US10646550B2Use of C-type natriuretic peptide variants to treat skeletal dysplasiaBIOMARIN PHARM INC·Filed 2018·Granted May 12, 2020·7 cites·13 claims
- 0390US8598121B2Variants of C-type natriuretic peptideWENDT DANIEL J·Filed 2012·Granted Dec 3, 2013·15 cites·14 claims
- 0488USRE48267EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2017·Granted Oct 20, 2020·2 cites·76 claims
- 0586US2024374688A1Use of C-Type Natriuretic Peptide Variants to Treat Skeletal DysplasiaBIOMARIN PHARM INC·Filed 2024·Application pending·0 cites
- 0682US12076372B2Use of C-type natriuretic peptide variants to treat skeletal dysplasiaBIOMARIN PHARM INC·Filed 2023·Granted Sep 3, 2024·0 cites·16 claims
- 0781US9907834B2Use of C-type natriuretic peptide variants to treat skeletal dysplasiaBIOMARIN PHARM INC·Filed 2016·Granted Mar 6, 2018·3 cites·8 claims
- 0869US11911446B2Use of C-type natriuretic peptide variants to treat skeletal dysplasiaBIOMARIN PHARM INC·Filed 2020·Granted Feb 27, 2024·0 cites·27 claims
- 0969US11590204B2Use of C-type natriuretic peptide variants to treat skeletal dysplasiaBIOMARIN PHARM INC·Filed 2020·Granted Feb 28, 2023·0 cites·33 claims
- 1066US2024358650A1Inhalable hormone receptor agonist formulationsPINATA HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1166US2025000806A1Dry Powdered FormulationsPINATA HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1265US2024358649A1Inhalable hormone receptor agonist formulationsPINATA HOLDINGS INC·Filed 2024·Application pending·0 cites
- 1362US4430433AProduction of aryl acylamidasesHEALTH LAB SERVICE BOARD·Filed 1981·Granted Feb 7, 1984·8 cites·26 claims
- 1459US2017051033A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2016·Application pending·0 cites
- 1556USRE46707EVariants of C-type natriuretic peptideBIOMARIN PHARM INC·Filed 2015·Granted Feb 13, 2018·0 cites·17 claims
- 1655US4414327AMethod for the estimation of N-acylated primary aromatic aminesHEALTH LAB SERVICE BOARD·Filed 1981·Granted Nov 8, 1983·6 cites·46 claims
- 1754US2016256553A1Variants of C-Type Natriuretic PeptideBIOMARIN PHARM INC·Filed 2015·Application pending·0 cites
- 1850US2024261227A1Inhalable Pharmaceutical FormulationsOGBURN MICHAEL·Filed 2022·Application pending·0 cites
- 1950US2024366660A1Delivery of Cellular Material and Other Material as a Dry PowderPINATA HOLDING INC·Filed 2022·Application pending·0 cites
- 2048US2024041782A1Oral Capsule Cannabinoid FormulationsOGBURN MICHAEL·Filed 2021·Application pending·0 cites
- 2147US2023372345A1Inhaled PDE-V Inhibitor DrugsOGBURN MICHAEL·Filed 2021·Application pending·0 cites
- 2247US2024050450A1Inhalable Cannabinoid FormulationsOGBURN MICHAEL·Filed 2021·Application pending·0 cites
- 2331US5714364APhenylalanine dehydrogenase productionMICROBIOLOGICAL RES AUTHORITY·Filed 1996·Granted Feb 3, 1998·2 cites·21 claims
- 2429US8252821B2Bioavailable capsule compositions of amorphous alpha-(N-sulfonamido)acetamide compoundCHANDRAN SACHIN·Filed 2010·Granted Aug 28, 2012·0 cites·30 claims
- 2524US5460948AAssay of salicylates or reduced pyridine nucleotidesHEALTH LAB SERVICE BOARD·Filed 1993·Granted Oct 24, 1995·3 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Christopher P. Price files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →